FibroBiologics (FBLG) Institutional Ownership $0.90 -0.05 (-5.26%) Closing price 03/31/2025 04:00 PM EasternExtended Trading$0.93 +0.03 (+3.00%) As of 03/31/2025 04:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for FibroBiologics (NASDAQ:FBLG)Number ofInstitutional Buyers(last 12 months)23TotalInstitutional Inflows(last 12 months)$10.61MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$216.26K Get FBLG Insider Trade Alerts Want to know when executives and insiders are buying or selling FibroBiologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data FBLG Institutional Buying and Selling by Quarter Remove Ads FibroBiologics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2025Jane Street Group LLC61,074$122K0.0%+415.3%0.168% 2/13/2025Raymond James Financial Inc.18,642$37K0.0%N/A0.051% 2/13/2025Cerity Partners LLC78,101$156K0.0%+49.9%0.215% 2/12/2025O Shaughnessy Asset Management LLC40,404$81K0.0%N/A0.111% 2/11/2025Virtu Financial LLC14,862$30K0.0%N/A0.041% 2/11/2025Intech Investment Management LLC12,653$25K0.0%N/A0.035% 2/7/2025Cascade Financial Partners LLC282,601$565K0.1%-6.6%0.803% 2/6/2025Raymond James Financial Inc.18,642$37K0.0%N/A0.053% 11/19/2024Barclays PLC39,958$123K0.0%+363.2%0.115% 11/16/2024Geode Capital Management LLC599,760$1.85M0.0%+90.0%1.706% Get the Latest News and Ratings for FBLG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for FibroBiologics and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024Barclays PLC39,958$123K0.0%+363.2%0.114% 11/15/2024Jane Street Group LLC11,852$37K0.0%N/A0.034% 11/15/2024State Street Corp475,837$1.47M0.0%+26.5%1.353% 11/13/2024The Manufacturers Life Insurance Company10,264$32K0.0%N/A0.029% 11/12/2024Charles Schwab Investment Management Inc.69,732$215K0.0%+5.2%0.198% 10/22/2024Symphony Financial Ltd. Co.23,772$76K0.0%N/A0.067% 8/14/2024Marshall Wace LLP16,702$83K0.0%-67.9%0.047% 8/12/2024Mercer Global Advisors Inc. ADV10,272$51K0.0%N/A0.029% 8/6/2024Fund Evaluation Group LLC1,055,105$5.27M0.3%N/A3.001% 8/6/2024Cahaba Wealth Management Inc.14,702$73K0.0%N/A0.041% 8/1/2024Rhumbline Advisers23,057$115K0.0%N/A0.065% 7/31/2024Cascade Financial Partners LLC315,055$1.57M0.2%N/A0.882% 7/31/2024Concurrent Investment Advisors LLC35,283$176K0.0%N/A0.099% 7/26/2024Bank of New York Mellon Corp68,558$342K0.0%N/A0.192% 7/23/2024RMR Wealth Builders37,360$186K0.0%N/A0.105% 7/18/2024Saxon Interests Inc.21,214$106K0.1%N/A0.059% 7/17/2024ERn Financial LLC31,819$159K0.0%N/A0.089% 7/15/2024Transform Wealth LLC133,890$668K0.1%N/A0.375% (Data available from 1/1/2016 forward)Remove Ads FBLG Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of FBLG shares? During the previous two years, 24 institutional investors and hedge funds held shares of FibroBiologics. The most heavily invested institutionals were Fund Evaluation Group LLC ($5.27M), Geode Capital Management LLC ($1.85M), State Street Corp ($1.47M), Transform Wealth LLC ($668K), Cascade Financial Partners LLC ($565K), Bank of New York Mellon Corp ($342K), and Charles Schwab Investment Management Inc. ($215K).Learn more on FBLG's institutional investors. Which institutional investors have been buying FibroBiologics stock? Of the 23 institutional investors that purchased FibroBiologics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Fund Evaluation Group LLC ($1.06M), Cascade Financial Partners LLC ($315.06K), Geode Capital Management LLC ($284.05K), Transform Wealth LLC ($133.89K), State Street Corp ($99.79K), Bank of New York Mellon Corp ($68.56K), and Barclays PLC ($62.66K). How much institutional buying is happening at FibroBiologics? Institutional investors have bought a total of 2,422,578 shares in the last 24 months. This purchase volume represents approximately $10.61M in transactions. Which FibroBiologics major shareholders have been selling company stock? The following institutional investors have sold FibroBiologics stock in the last 24 months: Marshall Wace LLP ($35.32K), and Cascade Financial Partners LLC ($20K). How much institutional selling is happening at FibroBiologics? Institutional investors have sold a total of 55,323 shares in the last 24 months. This volume of shares sold represents approximately $216.26K in transactions. Related Companies ADCT Institutional Ownership MOLN Institutional Ownership CYBN Institutional Ownership CCCC Institutional Ownership SCPH Institutional Ownership IVA Institutional Ownership HURA Institutional Ownership GLSI Institutional Ownership LRMR Institutional Ownership CGEN Institutional Ownership This page (NASDAQ:FBLG) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredLive Footage From Elon Musk’s “Area 51”What’s happening inside this nondescript building in South Memphis is so incredible… That Elon’s competitor...Brownstone Research | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | Sponsored“Massive Financial Reset Is Coming”The U.S. markets will see a massive reset, beginning days from now. But the "reset" isn't what you might ex...InvestorPlace | SponsoredGold Hits $3,000… Here’s How You Can Get More for Under $20With gold surging to record highs, currently trading above $3,000 an ounce, and central banks aggressively sto...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FibroBiologics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share FibroBiologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.